The natural compound triptolide was also shown to suppress breast cancer growth by directly reducing HMGB1 expression and secretion, thereby inhibiting downstream TLR4/NF-κB signaling and enhancing the efficacy of other HMGB1 inhibitors like EP [236]. Here, TLR4 is linked to breast carcinoma.